Berlin Patient

Timothy Ray Brown “The Berlin Patient” Memorial Campaign and Community Consortium Announced

Retrieved on: 
Wednesday, February 10, 2021
Gay men, Timothy Ray Brown, Berlin Patient, AIDS Memorial Grove, HIV/AIDS, Virology, Medicine, Health

San Francisco & Palm Springs, Feb. 10, 2021 (GLOBE NEWSWIRE) -- A consortium HIV/AIDS organizations have launched the Timothy Ray Brown The Berlin Patient Memorial Campaign (TRB Memorial Campaign), a community effort to memorialize Browns journey and life.The consortium will raise funds for a memorial boulder with a touching inscription in the National AIDS Memorial Grove in San Francisco and a memorial bench and plaqueinWellness Park adjacent to the Desert Regional Medical Center in Palm Springs.

Key Points: 
  • San Francisco & Palm Springs, Feb. 10, 2021 (GLOBE NEWSWIRE) -- A consortium HIV/AIDS organizations have launched the Timothy Ray Brown The Berlin Patient Memorial Campaign (TRB Memorial Campaign), a community effort to memorialize Browns journey and life.The consortium will raise funds for a memorial boulder with a touching inscription in the National AIDS Memorial Grove in San Francisco and a memorial bench and plaqueinWellness Park adjacent to the Desert Regional Medical Center in Palm Springs.
  • Timothy Ray Brownwas an American considered to be the first person curedof HIV/AIDS .Brown was diagnosed with HIV while studying abroad in Berlin, Germany in 1995, and later developed acute myeloid leukemia.
  • The coordinating consortium consists of the National AIDS Memorial, Lets Kick A.S.S.
  • The National AIDS Memorial is serving as fiscal sponsor for the Campaign.

CytoDyn Will Attempt to Duplicate Berlin and London Patients’ HIV Cure by Using Leronlimab During Bone Marrow Transplant for 5 HIV Patients Who also have Cancer

Retrieved on: 
Monday, August 17, 2020
Medical specialties, Branches of biology, Medicine, Stem cells, Transplantation medicine, CCR5, Berlin Patient, PRO 140, Hematopoietic stem cell transplantation, HIV, Bone marrow, Organ transplantation

CytoDyn plans to test this theory in a pilot clinical trial of five HIV patients with cancer who require bone marrow transplantation.

Key Points: 
  • CytoDyn plans to test this theory in a pilot clinical trial of five HIV patients with cancer who require bone marrow transplantation.
  • Leronlimab will be used during the peri-transplant period to mimic a CCR5 deficient donor in order to achieve HIV cure.
  • This protection is similar to that seen in individuals naturally CCR5 deficient and forms the rationale for use in HIV cure.
  • Our fourth path is an HIV-Cure, where 5 patients will be put to test to duplicate the Berlin and London patients HIV functional cure.

Enochian Biosciences Announces Three Scientific Presentations on Potential HIV and HBV Cures

Retrieved on: 
Wednesday, May 13, 2020
Medical specialties, HIV/AIDS, Medicine, Viruses, RTT, Hepatotoxins, Pandemics, HIV, Berlin Patient, Liver disease, Management of HIV/AIDS, Misconceptions about HIV/AIDS

Two presentations provide the first description of a novel approach to potentially cure HIV.

Key Points: 
  • Two presentations provide the first description of a novel approach to potentially cure HIV.
  • Two people the London Patient and the Berlin Patient have been cured of HIV following transplantation of cells with genetic mutations that prevent HIV infection.
  • Currently, we have good oral, safe and effective therapies that patients with HIV or chronic HBV must take daily, for life.
  • Non-compliance can lead to HIV and HBV viral resistance or to acute liver flares in patients with chronic liver disease.